Abstract: A channel scanning apparatus in a portable Internet system establishes a radio link with each of neighboring access points without disconnecting a wireless link with a serving access point and collects radio channel state information of each of the respective neighboring access points. That is, apart from a RF signal processing unit that processes a radio signal from the serving access point, the channel scanning apparatus includes a dedicated scanning processing unit for processing a radio signal of a neighboring access point and measuring radio channel state information of the neighboring access point from the radio signals received by the dedicated scanning processing unit, and collects radio channel state information of the respective neighboring access points. In such a way, communication with the serving access point is not disconnected, and therefore the access terminal and the serving access point do not need to buffer traffic data.

Abstract: A filtration device. The filtration device includes a tank, photocatalyst, a light source and a non-woven membrane module. The tank includes a reacting section and a separating section. The photocatalyst is added to water. The light source, disposed in the reacting section, provides light to react with the photocatalyst and thereby decompose pollutants in the water. The non-woven membrane module, disposed in the separating section, intercepts the photocatalyst in the water, producing purified water.

Abstract: The invention provides a method and apparatus for decoupling loss recovery from congestion and window control. The system provides improved performance in high loss environments such as wireless links. The system avoids unnecessary window adjustment in response to packet losses. Transmission rates can be maintained with out compromising loss recovery. The invention uses just-in-time Packet Expiration, Transmission Order Queue, a Forward Retransmission Algorithm and Window Control to provide improved performance. The invention maintains a queue of packets in flight called the Transmission Order Queue (TOQ). When an acknowledgement is received for a packet in the in-flight queue, that packet is removed from the queue. If a packet is still in the queue for a certain threshold time, the invention assumes that it is lost. At that point, the packet is removed from the in-flight queue and the packet is retransmitted.

Abstract: A system and method for estimating dynamic quantities is provided. The system includes an electronic identification recognition apparatus, a weight measuring apparatus, and a computing apparatus. The electronic identification recognition apparatus can recognize an electronic identification for a corresponding item placed into the system, and the weight measuring apparatus measures a total weight of all items that it carries. The computing apparatus is coupled to the weight measuring apparatus and the electronic identification recognition apparatus, for receiving the total weight, such that the quantity of the item can be estimated and recorded by using the total weights obtained respectively before and after the item is stored or removed and a recognition result from the electronic identification recognition apparatus.

Abstract: An exoskeleton worn by a human user consisting of a rigid pelvic harness worn about the waist of the user and exoskeleton leg structures each of which extends downwardly alongside one of the human user's legs. The leg structures include hip, knee and ankle joints connected by adjustable length thigh and shin members. The hip joint that attaches the thigh structure to the pelvic harness includes a passive spring or an active actuator to assist in lifting the exoskeleton and said human user with respect to the ground surface upon which the user is walking and to propel the exoskeleton and human user forward. A controllable damper operatively arresting the movement of the knee joint at controllable times during the walking cycle, and spring located at the ankle and foot member stores and releases energy during walking.

Abstract: A method for treating or inhibiting artery obstructive disease, such as restenosis after angioplasty and stenting procedures and stenosis after coronary artery bypass surgery, in a subject by administering to the subject a therapeutically effective amount of dasatinib or a derivative thereof Also provided are drug-eluting medical devices, including stents, having a therapeutically effective amount of dasatinib.

Abstract: A NOx removal system for boilers in which the need for any special heat retainer or any warming mechanism is eliminated. Ammonia jet nozzles are disposed on a gas passage of a boiler or flue, and an ammonia generator connected to the jet nozzles is disposed within the flue.

Abstract: A method for checking for elevated activity of mixed-function oxidases using a single insect, includes homogenizing a single insect in an acid pH buffer, preferably by grinding it in a small tube, such as an Eppendorf tube, with a pestle, adding a buffered tetramethylbenzidine solution as substrate, adding hydrogen peroxide as oxidant, and checking the blue coloration, the intensity of which indicates the degree of elevated mixed function oxidase activity. The invention also provides a test kit for use in the method which comprises separate containers of: I. an acid pH buffer, preferably an acid buffer about pH5 II. tetramethylbenzidine III. a solvent for tetramethylbenzidine, preferably methanol, and IV. hydrogen peroxide.

Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.

Abstract: A method and apparatus for determining forces to be applied to a user through a haptic interface. The method includes the steps of generating a representation of an object in graphic space, sensing the position of the user in real space and calculating a force to be applied to a user in response to the user's haptic interface and the user's fiducial object. The user's fiducial object represents the location in graphic space at which the user's haptic interface would be located if the haptic interface could not penetrate the surfaces of virtual objects.

Abstract: The present invention relates to an esterase, its DNA, its overexpression and a method for preparing an optically active aryl propionic acid of formula (1) using the same in high yield, wherein R1 represents an aryl group; and R2 represents a hydrogen atom.

Abstract: An apparatus for and a method of generating pointers for identifying structure boundaries of data for leased lines such as T1/E1 in an asynchronous transfer mode (ATM) adaptation layer Type 1 (AAL1) through an ATM layer.

Abstract: A procedure for diagnosing cochlear hydrops is based, in part, on an analysis of the patient's auditory brainstem response (ABR) to stimuli. The patient's ABR to a broadband click stimulus is recorded. A plurality of masked ABR's are also recorded, wherein the stimulus is masked by high-pass noise with a plurality of high-pass cut-off frequencies. The latency difference between the wave V component in the unmasked click alone response and the undermasked wave V component of a low cut-off frequency high-pass response is then calculated. If an undermasked component is not present, the normal wave V component is used. The measured latency difference is combined with another measure, such as the wave V amplitude ratio. A distribution of the combined measure is then plotted for the population and a threshold established for diagnosing cochlear hydrops. Alternatively, the joint distribution of the individual measures may be used in situations where the individual measures are known to be independent.

Abstract: The present invention relates to bicyclic tetrahydrofuran lactone derivatives of Formula (1) and a preparation method thereof, and particularly it relates to a process of preparing compounds of Formula (1) by performing an intramolecular cyclization of tetrahydrofuran-allenic acid derivatives in the presence of a phenyl halide, a palladium catalyst and a base: wherein n is 1 or 2, and R is phenyl optionally substituted with C1–C6 alkyl, C1–C6 alkoxy, hydroxyl or C1–C6 hydroxyalkyl group.

Abstract: An enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal?1-4Glc or Gal?1-4GlcNAc-group via a ?-1,3 bond; a nucleic acid encoding the same; and a method of diagnosing cancer and/or tumor, in particular, digestive cancer and/or tumor using the expression dose of a gene of the above enzyme as an indication. A gene of a novel enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal ?1-4Glc or Gal ?1-4GlcNAc-group via a ?-1,3 bond is cloned from human stomach cells and its base sequence is determined. Then this enzyme is expressed. Since this enzyme is scarcely or never produced in cancer and/or tumor, in particular, digestive cancer and/or tumor cells, cancer and/or tumor can be diagnosed with the use of the expression of the enzyme gene as an indication.

Abstract: The present invention relates to a method for determining a nucleotide sequence of a nucleic acid by detecting a single dye molecule.

Abstract: A herpesvirus vaccine comprising a mutated herpesvirus suspended in a pharmaceutically acceptable carrier. The mutated herpesvirus is capable of infecting cells of the mammal to be vaccinated, but incapable of completing a replicative cycle, and it is capable of eliciting a protective immune response in that mammal. The mutated herpesvirus is also capable of treating immunomodulatory or immunoregulatory diseases. The mutation occurs in at least one gene encoding a protein essential for replication of the virus, so that the mutation renders the virus replication defective.

Abstract: A microwave burning furnace including a housing constituted by a metal on which a microwave is to be irradiated, a metallic door provided in the housing, a burning chamber provided in the housing and surrounded by a material having a low microwave absorption characteristic and a high heat insulating property, and microwave generating means, wherein the burning chamber includes a heater element constituted by at least two types of heating materials having a heating material for a high temperature region which automatically generates a heat mainly in the high temperature region to have a burning temperature by an irradiation of a microwave and a heating material for a low temperature region which automatically generates a heat mainly in the low temperature region including an ordinary temperature.

Abstract: A method of fabricating a thermal conductive plug of a ceramic substrate of a multi-chip package. A plurality of conductive openings and thermal conductive openings are formed on green tapes. A metal paste is filled into the conductive openings and the thermal conductive openings. The green tapes are stacked together so that the metal paste inside the conductive openings and the thermal conductive openings of every green tape is in contact respectively with its neighboring metal paste within the conductive openings and thermal conductive openings of the green tapes. Cofire those green tapes and the metal paste to form a pre-substrate. The pre-substrate comprises an insulating structure, a plurality of thermal conductive plugs and conductive plugs.

Abstract: A new and distinct kiwi plant of the species Actinidia chinensis Planch. is described. The variety results from a controlled pollination using a female A. chinensis selection ‘Jing Feng’ (also known as 79-3, and by the accession code CK34_01) of unknown parentage, and a male A. chinensis selection CK40_02 of unknown parentage. Both parents (‘Jing Feng’ and CK40_02) are unpatented. The new variety is distinguished by its large globose-shaped fruit with a flat stylar end, golden coloured flesh and tangy sweet taste.